Cargando…
Integrins and cadherins as therapeutic targets in fibrosis
Fibrosis is the excessive deposition of extracellular matrix proteins into tissues leading to scar formation, disruption of normal tissue architecture and organ failure. Despite the large clinical impact of fibrosis, treatment options are limited. Adhesion molecules, in particular αvβ6 and α3β1 inte...
Autor principal: | Agarwal, Sandeep K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042084/ https://www.ncbi.nlm.nih.gov/pubmed/24917820 http://dx.doi.org/10.3389/fphar.2014.00131 |
Ejemplares similares
-
β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
por: Blandin, Anne-Florence, et al.
Publicado: (2015) -
Targeting of cadherin-11 decreases skin fibrosis in the tight skin-1 mouse model
por: Pedroza, Mesias, et al.
Publicado: (2017) -
Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride
por: Pedroza, Mesias, et al.
Publicado: (2019) -
Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017) -
Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis
por: Feng, Fan, et al.
Publicado: (2022)